OK Biotech Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 13, 2023 at 09:27 pm EDT
Share
OK Biotech Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 319.39 million compared to TWD 435.89 million a year ago. Net income was TWD 15.06 million compared to TWD 53.77 million a year ago. Basic earnings per share from continuing operations was TWD 0.118 compared to TWD 0.5172 a year ago. Diluted earnings per share from continuing operations was TWD 0.118 compared to TWD 0.4718 a year ago.
For the six months, sales was TWD 640.42 million compared to TWD 853.02 million a year ago. Net income was TWD 33.09 million compared to TWD 102.47 million a year ago. Basic earnings per share from continuing operations was TWD 0.2722 compared to TWD 0.989 a year ago. Diluted earnings per share from continuing operations was TWD 0.2631 compared to TWD 0.871 a year ago.
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
OK BIOTECH CO., LTD. 
